MicroRNA-24 regulates vascularity after myocardial infarction.
about
Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative StressRole and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular BiologyLooking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium SurvivalMicroRNAs; easy and potent targets in optimizing therapeutic methods in reparative angiogenesismiRNA therapeutics in cardiovascular diseases: promises and problemsEpigenetic mechanisms underlying cardiac degeneration and regenerationRho GAPs and GEFs: controling switches in endothelial cell adhesionNon-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and DiseaseRole of microRNAs in the reperfused myocardium towards post-infarct remodellingTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologymiRNome in myocardial infarction: Future directions and perspectiveDifferential expression of microRNAs in different disease states.Facts and updates about cardiovascular non-coding RNAs in heart failureRegulatory non-coding RNAs in acute myocardial infarctionDeveloping miRNA therapeutics for cardiac repair in ischemic heart diseasemicroRNA-200b as a Switch for Inducible Adult AngiogenesisMolecular mechanisms of ischemic preconditioning in the kidneyNoncoding RNA in age-related cardiovascular diseasesThe role of microRNAs in regulating myocardial ischemia reperfusion injurymiR-24 triggers epidermal differentiation by controlling actin adhesion and cell migrationSON protein regulates GATA-2 through transcriptional control of the microRNA 23a~27a~24-2 clusterPAK signalling during the development and progression of cancerRole of miR-24, Furin, and Transforming Growth Factor-β1 Signal Pathway in Fibrosis After Cardiac InfarctionIdentification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseasesRepression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24.miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.Expression of microRNA-122 contributes to apoptosis in H9C2 myocytes.Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome.MicroRNA-122 regulates caspase-8 and promotes the apoptosis of mouse cardiomyocytes.MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signalingNon-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression.Bone mesenchymal stem cells ameliorate ischemia/reperfusion-induced damage in renal epithelial cells via microRNA-223Maternal pak4 expression is required for primitive myelopoiesis in zebrafishHypoxamiR regulation and function in ischemic cardiovascular diseases.Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2Cardiovascular importance of the microRNA-23/27/24 family.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesGenetic module and miRNome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations.Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.
P2860
Q26744498-ACB666D4-DD30-4E28-ACA7-504F607A17FCQ26777595-1D02FFDA-0866-4E7B-A84D-33CF0D79C042Q26778539-709FA3D3-532C-435F-9A4D-D0CA38AAA3E0Q26785405-F46D0B68-0A1B-41FD-B048-9595A2CA5A08Q26801614-7FBF552F-3716-4B9A-A78D-4182A38B6D08Q26853220-4ECF76F3-A8F1-4A0C-ACBD-1F5394DED1F1Q26992281-D372EB5D-53A3-41F6-B08A-818981354492Q26999363-FA73F379-BFFF-42AA-9822-67F72E82B41CQ27000076-378B1633-BBDE-4491-89EA-6785DB879A49Q27024879-DC3E1B1A-B461-41DA-9297-6618B6D56D14Q27028108-DEBD8662-5F0A-40AE-A8B4-C8331CF056F2Q27693279-86162456-7374-4677-94E6-8757A0E745D2Q28072307-2EDF673B-66CC-4E3C-8445-574A8CF2FD27Q28077279-212EA03C-AA86-43E0-887E-9EA1DF296834Q28077986-9E5513DB-4A53-4BC3-89E1-D73EFAFB312DQ28080485-C13F78A5-6DC9-4E85-A9FC-F492FD90CACCQ28080772-0B4020C7-D202-41DA-BAB9-D4A139AD0289Q28081466-4C06CCA2-C43B-4DFB-86B0-45A92B631F8BQ28088604-C100CE69-8898-4AFD-87BD-E539F817B42FQ28277153-8B1C216B-B731-4AC8-9180-1BC39392E207Q28283462-D30C6D01-96CC-4577-84AB-271E7BCF833CQ28307460-18396802-4031-42C8-B742-0AD5CF819C61Q28468607-9E432BCC-41FA-4CEE-82DF-9A9172D35B12Q28583018-73380977-F518-4925-B143-1A21A791B7CEQ30571075-054FD209-770A-4F43-B6BD-60DF3205CA36Q30596758-3395C016-3B03-40EE-9467-26F487C98264Q33112263-0EDD6D3E-2DA6-411C-8A41-83C4891BF615Q33403833-17F7D3BE-6A58-4304-B057-7C3ED71E6DC0Q33560963-1FE3FC4C-B644-4228-BE80-46FECF30AF69Q33799083-0FD55DBE-6E8F-4B6C-A9E1-821A5404AF94Q33804552-B8DBA60B-1EFD-41A6-933D-997834DDF928Q33805451-D9F50787-70DF-46EA-BA26-9A38AD3B6332Q34044974-0D664ECA-19CA-4AF6-9942-8EDA55E1659BQ34082010-DE43E4FD-FBEF-4D45-B065-35BA317A3B45Q34231577-8F7D1A99-374E-4355-8295-E3724161E43AQ34237674-6DE5A160-9B6B-442F-9CA9-2186E247BFA3Q34391443-2457DE7F-6097-404B-9A3E-4D1990F83E37Q34401880-F15F465D-2DF4-4496-9ED6-361BE2AC7134Q34485522-6918C7E9-C9E6-4486-9058-34FCD4ECF17FQ34504964-9B0A3712-136B-4880-9E56-0436699C10E7
P2860
MicroRNA-24 regulates vascularity after myocardial infarction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
MicroRNA-24 regulates vascularity after myocardial infarction.
@en
MicroRNA-24 regulates vascularity after myocardial infarction.
@nl
type
label
MicroRNA-24 regulates vascularity after myocardial infarction.
@en
MicroRNA-24 regulates vascularity after myocardial infarction.
@nl
prefLabel
MicroRNA-24 regulates vascularity after myocardial infarction.
@en
MicroRNA-24 regulates vascularity after myocardial infarction.
@nl
P2093
P50
P921
P1433
P1476
MicroRNA-24 regulates vascularity after myocardial infarction.
@en
P2093
Bettina C Kirchmaier
Cherin Sohn-Lee
Dorothee Hartmann
Georg Ertl
Jan Fiedler
Joerg Heineke
Johan Lorenzen
Johann Bauersachs
John T G Pena
Juergen Soutschek
P304
P356
10.1161/CIRCULATIONAHA.111.039008
P407
P577
2011-07-25T00:00:00Z